Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration

MLA

Roger L. Novack, et al. “Phase Ii, Randomized, Placebo-Controlled, 90-Day Study of Emixustat Hydrochloride in Geographic Atrophy Associated with Dry Age-Related Macular Degeneration.” Retina (Philadelphia, Pa.), vol. 35, no. 6, May 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a3083acac5095ed74853c22bf3b5c186&authtype=sso&custid=ns315887.

APA

Roger L. Novack, Preston P. Richmond, Karl G. Csaky, David G. Birch, Pravin U. Dugel, & Ryo Kubota. (2015). Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration. Retina (Philadelphia, Pa.), 35(6).

Chicago

Roger L. Novack, Preston P. Richmond, Karl G. Csaky, David G. Birch, Pravin U. Dugel, and Ryo Kubota. 2015. “Phase Ii, Randomized, Placebo-Controlled, 90-Day Study of Emixustat Hydrochloride in Geographic Atrophy Associated with Dry Age-Related Macular Degeneration.” Retina (Philadelphia, Pa.) 35 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a3083acac5095ed74853c22bf3b5c186&authtype=sso&custid=ns315887.